Who owns Vertex Pharmaceuticals Incorporated?

Key details on Vertex Pharmaceuticals Incorporated (Ticker: VRTX)

Who owns Vertex Pharmaceuticals Incorporated?

Is VRTX a good stock to own? Find out who bought Vertex Pharmaceuticals Incorporated, who sold Vertex Pharmaceuticals Incorporated (VRTX) stock, and who holds a large position in Vertex Pharmaceuticals Incorporated.

Fund Name Number of Shares Share Valuation As Of
Capital World Investors^ 26.38M $2.50B June 30, 2014
Vanguard 16.70M $1.58B June 30, 2014
Wellington Management Company 16.46M $1.56B June 30, 2014
T. Rowe Price Associates 13.87M $1.31B June 30, 2014
Jennison Associates 12.32M $1.17B June 30, 2014
STATE STREET CORPORATION 9.96M $943.19M June 30, 2014
JPMORGAN CHASE & CO 9.64M $912.34M June 30, 2014
ClearBridge Advisors 7.55M $714.78M June 30, 2014
Ameriprise Financial 7.08M $670.20M June 30, 2014
FMR 6.61M $467.37M March 31, 2014
BlackRock Institutional Trust Company, N.A. 6.19M $695.42M Sept. 30, 2014
BlackRock Fund Advisors 5.61M $629.89M Sept. 30, 2014
Janus Capital Management 5.09M $405.72M June 30, 2013
GOLDMAN SACHS 4.60M $325.31M March 31, 2014
D. E. Shaw & Co 4.22M $235.76M June 30, 2012
Westfield Capital Management Company 3.88M $159.16M March 31, 2012
Waddell & Reed Financial 3.81M $360.62M June 30, 2014
Loomis, Sayles and 3.75M $278.94M Dec. 31, 2013
Neuberger Berman 3.74M $156.63M Dec. 31, 2012
ALLIANCEBERNSTEIN 3.72M $152.74M March 31, 2012
Sectoral Asset Management 3.67M $204.84M Sept. 30, 2012
Lazard Asset Management 3.65M $291.53M June 30, 2013

Who sold Vertex Pharmaceuticals Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
Brookside Capital Management, LLC* Sept. 30, 2011 5.19M $230.74M
BB Biotech AG March 31, 2011 3.95M $189.32M